Alkem Laboratories Ltd (NSE:ALKEM)
₹ 5692.75 50.3 (0.89%) Market Cap: 680.65 Bil Enterprise Value: 648.04 Bil PE Ratio: 31.01 PB Ratio: 5.73 GF Score: 98/100

Q1 2025 Alkem Laboratories Ltd Earnings Call Transcript

Aug 09, 2024 / 11:30AM GMT
Release Date Price: ₹5796.85 (+1.93%)
Operator

Ladies and gentlemen, good day, and welcome to the Alkem Lab Q1 FY25 earnings call hosted by Motilal Oswal Financial Services Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Tushar Manudhane from Motilal Oswal. Thank you, and over to you, sir.

Tushar Manudhane
Motilal Oswal Financial Services Ltd - Analyst

Thanks, Siddhant. Good evening, and a warm welcome for 1Q FY25 earnings call of Alkem Laboratories. So on the management side, we have Dr. Vikas Gupta, CEO; Mr. Nitin Agrawal, CFO; and Ms. Purvi Shah, Head of Investor Relations. Over to you, Vikas, sir, for the opening remarks.

Purvi Shah
Alkem Laboratories Ltd - IR

Thank you, Tushar. So good evening, everyone. Earlier in the day, we have released our financial results, press release and investor presentation, which are also posted on our website. We hope you all had the opportunity to review it.

Before we proceed with this call, we'd like to remind everyone that this is being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot